Contract

EndoSign® Capsule Sponge Devise and Diagnostic Report.

  • Somerset NHS Foundation Trust

F03: Contract award notice

Notice identifier: 2025/S 000-066488

Procurement identifier (OCID): ocds-h6vhtk-05989d (view related notices)

Published 17 October 2025, 4:52pm



Section one: Contracting authority

one.1) Name and addresses

Somerset NHS Foundation Trust

Musgrove Park Hospital

Taunton

TA1 5DA

Contact

Hollie Caddy

Email

servicesteam.procurement@somersetft.nhs.uk

Country

United Kingdom

Region code

UKK23 - Somerset

Internet address(es)

Main address

https://www.somersetft.nhs.uk/

Buyer's address

https://www.somersetft.nhs.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

EndoSign® Capsule Sponge Devise and Diagnostic Report.

Reference number

CLIN100

two.1.2) Main CPV code

  • 85111800 - Pathology services

two.1.3) Type of contract

Services

two.1.4) Short description

Provision of consumables and diagnostic service for detecting Barrett's esophagus. This is an introduction of a non-invasive procedure to deliver benefits to patients including earlier detection and improved outcomes.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £316,848

two.2) Description

two.2.2) Additional CPV code(s)

  • 33140000 - Medical consumables

two.2.3) Place of performance

NUTS codes
  • UKK23 - Somerset
Main site or place of performance

Somerset NHS Foundation Trust Sites

two.2.4) Description of the procurement

Provision of consumables and diagnostic service for detecting Barrett's esophagus. By introducing a non-invasive procedure, the aim is to deliver significant benefits to patients, including earlier detection, reduced waiting times, and improved outcomes.
The Trust plans to enter into a 12-month contract with a single supplier capable of providing both consumables and diagnostic services as an integrated solution. This initiative is not a product trial but rather a pilot project to assess the Trust's capacity and capability for long-term service delivery and will include a 12 month extension option.

This is a notice with the intention to award a contract under the most suitable provider process. This is a new service, with a new provider and the contract is expected to be live between November 2025 and October 2026. The expected lifetime value of the contract is £316,848.00.

two.2.5) Award criteria

Cost criterion - Name: Provider Selection Regime / Weighting: 100

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight on 29 October 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2025/S 000-055810


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

17 October 2025

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Cyted Health Ltd

2 Falcon Road, Hinchingbrooke Business Park, Huntingdon, Cambridgeshire

Cambridge

PE29 6FG

Email

finance@cyted.ai

Telephone

+44 1480453437

Country

United Kingdom

NUTS code
  • UKH12 - Cambridgeshire CC
National registration number

15199818

The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £316,848

Total value of the contract/lot: £316,848


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

The decision makers were: Cancer Programme Manager

No conflicts of interest were declared among decision makers.

The key criteria were weighted as follows:
25% quality and Innovation
20% Value
20% Integration, Collaboration and Service Sustainability
25% Improving access, reducing health inequalities and facilitating choice
10% Social value
The highest weightings have been applied to ensure a high quality, safe and effective services that are fully integrated in the healthcare system and that provide improved access, reduce health inequalities and facilitate chouse. These are the most important elements of the service.

Value for money is also an important element to ensure the service can be provided to as many patients as possible to minimise waiting times.

The rationale for choosing the provider with reference to the key criteria:
The supplier selected is the only one who is able to provide both the capsule sponge and testing as one solution. The pathology element is proprietary to the supplier selected.

six.4) Procedures for review

six.4.1) Review body

Somerset NHS Foundation Trust

Musgrove Park Hospital

Taunton

TA1 5DA

Country

United Kingdom

Internet address

https://www.somersetft.nhs.uk/

six.4.2) Body responsible for mediation procedures

NHS England

Wellington House, 133-135 Waterloo Rd

London

SE1 8UG

Email

england.commercialqueries@nhs.net

Country

United Kingdom

Internet address

https://www.england.nhs.uk/